Efficacy and Safety of Actonel ® After Denosumab Discontinuation in Postmenopausal Osteoporosis Women

Condition:   Postmenopausal Osteoporosis Interventions:   Drug: Risedronate Sodium 35 MG [Actonel];   Drug: Calcium Vitamin D combination Sponsor:   Dong-A ST Co., Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials